These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27826241)

  • 1. Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability Interplay.
    Beig A; Lindley D; Miller JM; Agbaria R; Dahan A
    Front Pharmacol; 2016; 7():379. PubMed ID: 27826241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility-permeability interplay of hydrotropic solubilization of piroxicam.
    Nainwal N; Jawla S; Singh R; Banerjee S; Saharan VA
    Drug Dev Ind Pharm; 2024 Jun; 50(6):481-494. PubMed ID: 38717346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels.
    Beig A; Miller JM; Lindley D; Dahan A
    Mol Pharm; 2017 Jan; 14(1):319-327. PubMed ID: 27981848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Hydrotropic Solubilization Techniques for Enhancing the Bioavailability of Poorly Soluble Drugs.
    Sharma U; Saroha K
    Int J Toxicol; 2024; 43(1):63-71. PubMed ID: 37999970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation.
    Miller JM; Beig A; Krieg BJ; Carr RA; Borchardt TB; Amidon GE; Amidon GL; Dahan A
    Mol Pharm; 2011 Oct; 8(5):1848-56. PubMed ID: 21800883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs.
    Kim JY; Kim S; Pinal R; Park K
    J Control Release; 2011 May; 152(1):13-20. PubMed ID: 21352878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrotrope accumulation around the drug: the driving force for solubilization and minimum hydrotrope concentration for nicotinamide and urea.
    Booth JJ; Omar M; Abbott S; Shimizu S
    Phys Chem Chem Phys; 2015 Mar; 17(12):8028-37. PubMed ID: 25723588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of aceclofenac injection made by mixed hydrotropic solubilization technique.
    Kumar Maheshwari R; Indurkhya A
    Iran J Pharm Res; 2010; 9(3):233-42. PubMed ID: 24363732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methacrylate-Copolymer Eudragit EPO as a Solubility-Enabling Excipient for Anionic Drugs: Investigation of Drug Solubility, Intestinal Permeability, and Their Interplay.
    Fine-Shamir N; Dahan A
    Mol Pharm; 2019 Jul; 16(7):2884-2891. PubMed ID: 31120762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption.
    Beig A; Miller JM; Dahan A
    Eur J Pharm Biopharm; 2012 Jun; 81(2):386-91. PubMed ID: 22387337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic property.
    Lee J; Lee SC; Acharya G; Chang CJ; Park K
    Pharm Res; 2003 Jul; 20(7):1022-30. PubMed ID: 12880288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic studies on hydrotropic solubilization of nifedipine in nicotinamide solution.
    Suzuki H; Sunada H
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):125-30. PubMed ID: 9468644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solubility, permeability and the dose as key factors in formulation development for oral lipophilic drugs: Maximizing the bioavailability of carbamazepine with a cosolvent-based formulation.
    Fine-Shamir N; Beig A; Miller JM; Dahan A
    Int J Pharm; 2020 May; 582():119307. PubMed ID: 32276090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
    Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
    Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplay.
    Beig A; Agbaria R; Dahan A
    Eur J Pharm Sci; 2015 Sep; 77():73-8. PubMed ID: 26006306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU.
    Takahashi K; Komai M; Kinoshita N; Nakamura E; Hou XL; Takatani-Nakase T; Kawase M
    J Pharm Pharmacol; 2011 Aug; 63(8):1008-14. PubMed ID: 21718283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol-based solubility-enabling oral drug formulation development: Accounting for the solubility-permeability interplay.
    Fine-Shamir N; Dahan A
    Int J Pharm; 2024 Mar; 653():123893. PubMed ID: 38346600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid hydrotropes to increase the solubility of indomethacin and carbamazepine in aqueous solution.
    Alsalhi MS; Chan KLA
    Int J Pharm; 2022 Apr; 617():121591. PubMed ID: 35183692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations of hydrotropic solubilization and self-aggregation of nicotinamide.
    Cui Y; Xing C; Ran Y
    J Pharm Sci; 2010 Jul; 99(7):3048-59. PubMed ID: 20112429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM; Beig A; Carr RA; Spence JK; Dahan A
    Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.